Showing results (191-200 of 201) with videos related to
Sort By:
Pageof 21
JAMA Oncology|March 1, 2019
Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMTAbraham S Kanate, Ambuj Kumar, Peter Dreger, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 26, 2019
Noncontrast CT versus Perfusion-Based Core Estimation in Large Vessel Occlusion: The Blood Pressure after Endovascular Stroke Therapy StudyJames E Siegler, Steven R Messé, Heidi Sucharew, et al.Blood Advances|October 1, 2020
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapiesDavid Sermer, Connie Batlevi, M Lia Palomba, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell LymphomaEdward R Scheffer Cliff, Guido D Pelaez, Fei Wan, et al.BMJ Mental Health|August 10, 2023
Living alone and mental health: parallel analyses in UK longitudinal population surveys and electronic health records prior to and during the COVID-19 pandemicEoin McElroy, Emily Herrett, Kishan Patel, et al.Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.Neurosurgery|November 24, 2019
Thrombectomy in DAWN- and DEFUSE-3-Ineligible Patients: A Subgroup Analysis From the BEST Prospective Cohort StudyJames E Siegler, Steven R Messé, Heidi Sucharew, et al.Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.Stroke|October 8, 2019
Blood Pressure after Endovascular Therapy for Ischemic Stroke (BEST): A Multicenter Prospective Cohort StudyEva A Mistry, Heidi Sucharew, Akshitkumar M Mistry, et al.Blood Cancer Journal|June 14, 2018
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assayAndrew M Intlekofer, Erel Joffe, Connie L Batlevi, et al.Pageof 21